Abstract:Introduction: In vivo screening studies, in which the efficacy of dozens of drugs is tested to select several applicants for further study of their safety in humans, are the main stage in the study of the pharmacodynamics of promising antiglaucoma drugs. This imposes a number of specific requirements both on experimental models of glaucoma and on laboratory animals used in the experiment. Materials and Methods: 32 male rabbits of the Soviet Сhinchilla breed, 6 male albino rabbits weighing 3-3.5 kg, and 20 outbred white rats weighing 220-250 g were used in total in experiments to reproduce the glaucoma process. All manipulations on the rabbit eye were performed by an ophthalmologist under general anesthesia with telazol. Triamcinolone (vitreous injection) was used to simulate glaucoma in rabbits, lauromacrogol 400 or fine kaolin (anterior chamber injection) was used to simulate glaucoma in rabbits; adrenaline hydrochloride (intraperitoneal administration) was used to simulate glaucoma in rats. Results and Discussion: Double intravitreal administration of a suspension of triamcinolone at a dose of 4 mg was the most attractive model in terms of the technique of reproducing the pathology and the results obtained in modeling glaucoma in rabbits. However, this model did not produce a stable increase in intraocular pressure (IOP). Doubling the dose of triamcinolone and replacing chinchilla rabbits with albinos did not lead to a positive result. The introduction of the venous sclerosing drug lauromacrogol 400 into the anterior chamber of the eye proved to be ineffective either. The introduction of finely dispersed kaolin into the anterior chamber of the eye of rabbits led to a persistent increase in IOP. The intraperitoneal administration of epinephrine hydrochloride to rats according to the described method gave no stable results. The increase in IOP became stable only after a significant increase in the dose of adrenaline. Conclusion: The conducted studies of four models of glaucoma and their three modifications in animals made it possible to select two of them, which contributed to a stable and fairly long-term increase in IOP in rabbits (introduction of finely dispersed kaolin into the anterior chamber of the eye) and rats (adrenaline-induced model).

Animal Models of Glaucoma

The Rodent Model of Glaucoma and Its Implications.

Glaucoma Animal Models beyond Chronic IOP Increase

[Progress of Chronic Ocular Hypertensive Glaucoma in Rodents].

Rodent models of glaucoma and their applicability for drug discovery

Genetic rodent models of glaucoma in representing disease phenotype and insights into the pathogenesis

Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities

Exploring the current use of animal models in glaucoma drug discovery: where are we in 2023?

Animal models as windows into the pathogenesis of myopia: Illuminating new directions for vision health

Angiopoietin-1 Knockout Mice As a Genetic Model of Open-Angle Glaucoma

Animal modeling for myopia

In Situ-Crosslinked Hydrogel-Induced Experimental Glaucoma Model with Persistent Ocular Hypertension and Neurodegeneration.

Fundus Photography, Fundus Fluorescein Angiography, and Optical Coherence Tomography of Healthy Cynomolgus Monkey, New Zealand Rabbit, Sprague Dawley Rat, and BALB/c Mouse Retinas

Molecular pathways in experimental glaucoma models

In Vivo Models of Steroid-Induced Intraocular Hypertension

Rabbit Models of Ocular Diseases: New Relevance for Classical Approaches

Modeling experimental glaucoma for screening studies of antiglaucomatous activity

Microglial involvement in ocular hypertension

[Changes of Neuroglia Cells in Human Glaucoma and Animal Model of Experimental Glaucoma].

Research advances in the animal models and pathogenic mechanisms of myopia

Longitudinal evaluation of morphological, functional and vascular alterations in a rat model of experimental glaucoma